CIK 0001811115 · <br>Emerging growth company
Renalytix plc
Sign in to watch- Ticker
- RENXF
- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- FY end
- Jun 30
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 29 2071 0570
- Business address
- FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom
- Former names
- Renalytix AI plc
Securities
- RENXF Common stock OTC
- RNLXY American depositary shares OTC
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- F-6 POS Other F-6 POS
- F-6 POS Other F-6 POS
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 15-12G Other 15-12G
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 1 of 12 · 233 filings